Publications 2023

Membrane-derived particles shed by PSMA-positive cells function as pro-angiogenic stimuli in tumors 

Machado CM, Skubal M, Haedicke K, Silva FP, Stater EP, Silva TL, Costa ET, Masotti C, Otake AH, Andrade LN, Junqueira Md, Hsu HT, Das S, Larney BM, Pratt EC, Romin Y, Fan N, Manova-Todorova K, Pomper M, Grimm J, 2023 Dec Journal of Controlled Release 364 312-325

Clinical and Genomic Differences Between Advanced Molecular Imaging-detected and Conventional Imaging-detected Metachronous Oligometastatic Castration-sensitive Prostate Cancer 

Sutera P, Song Y, Van der Eecken K, Shetty AC, English K, Hodges T, Chang J, Fonteyne V, Rana Z, Ren L, Mendes AA, Lumen N, Delrue L, Verbeke S, De Man K, Song DY, Pienta K, Feng FY, Joniau S, Lotan T, Lane B, Kiess A, Rowe S, Pomper M, DeWeese T, Deek M, Sweeney C, Ost P, Tran PT, 2023 Dec European Urology 84 531-535

Prostate-specific Membrane Antigen Reporting and Data System Version 2.0 

Werner RA, Hartrampf PE, Fendler WP, Serfling SE, Derlin T, Higuchi T, Pienta KJ, Gafita A, Hope TA, Pomper MG, Eiber M, Gorin MA, Rowe SP, 2023 Nov European Urology 84 491-502

Role of Functional SPECT and PET in Renal Emergencies 

Higuchi T, Hartrampf PE, Buck AK, Pomper MG, Rowe SP, Serfling SE, Werner RA, 2023 Nov Seminars in Nuclear Medicine 53 786-796

Imaging Brain Injury in Former National Football League Players 

Rubin LH, Du Y, Sweeney SE, O'toole R, Thomas CL, Zandi AG, Shinehouse LK, Brosnan MK, Nam H, Burke ME, Bureau SC, Kilgore JJ, Yoon M, Soule AR, Lesniak WG, Minn I, Rowe SP, Holt DP, Hall AW, Mathews WB, Smith GS, Nowinski CJ, Kassiou M, Dannals RF, Pomper MG, Coughlin JM, 2023 Oct JAMA Network Open 6

Serotonin Degeneration and Amyloid-β Deposition in Mild Cognitive Impairment: Relationship to Cognitive Deficits 

Smith GS, Kuwabara H, Yan H, Nassery N, Yoon M, Kamath V, Kraut M, Gould NF, Savonenko A, Coughlin JM, Lodge M, Pomper MG, Nandi A, Holt D, Dannals RF, Leoutsakos JM, 2023 Oct Journal of Alzheimer's Disease 96 215-227

Non-invasive PD-L1 quantification using [18F]DK222-PET imaging in cancer immunotherapy 

Mishra A, Gupta K, Kumar D, Lofland G, Sharma AK, Solnes LB, Rowe SP, Forde PM, Pomper MG, Gabrielson EW, Nimmagadda S, 2023 Oct Journal for ImmunoTherapy of Cancer 11

[18F]FNDP PET neuroimaging test–retest repeatability and whole-body dosimetry in humans 

Du Y, Coughlin JM, Amindarolzarbi A, Sweeney SE, Harrington CK, Brosnan MK, Zandi A, Shinehouse LK, Sanchez AN, Abdallah R, Holt DP, Fan H, Lesniak WG, Nandi A, Rowe SP, Solnes LB, Dannals RF, Horti AG, Lodge MA, Pomper MG, 2023 Oct European Journal of Nuclear Medicine and Molecular Imaging 50 3659-3665

First-in-Human Study of the Radioligand 68Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma 

Duan X, Xia L, Zhang Z, Ren Y, Pomper MG, Rowe SP, Li X, Li N, Zhang N, Zhu H, Yang Z, Sheng X, Yang X, 2023 Sep Clinical Cancer Research 29 3395-3407

Test–retest repeatability of organ uptake on PSMA-targeted 18F-DCFPyL PET/CT in patients with prostate cancer 

Werner RA, Lütje S, Habacha B, Bundschuh L, Higuchi T, Buck AK, Kosmala A, Lapa C, Essler M, Lodge MA, Pienta KJ, Eisenberger MA, Markowski MC, Gorin MA, Pomper MG, Rowe SP, Bundschuh RA, 2023 Sep Prostate 83 1186-1192

SUVmean on baseline [18F]PSMA-1007 PET and clinical parameters are associated with survival in prostate cancer patients scheduled for [177Lu]Lu-PSMA I&T 

Hartrampf PE, Hüttmann T, Seitz AK, Kübler H, Serfling SE, Schlötelburg W, Michalski K, Rowe SP, Pomper MG, Buck AK, Eberlein U, Werner RA, 2023 Sep European Journal of Nuclear Medicine and Molecular Imaging 50 3465-3474

Preclinical Development in Radiopharmaceutical Therapy for Prostate Cancer 

Alati S, Singh R, Pomper MG, Rowe SP, Banerjee SR, 2023 Sep Seminars in Nuclear Medicine 53 663-686

Preclinical Evaluation of a New Series of Albumin-Binding 177Lu-Labeled PSMA-Based Low-Molecular-Weight Radiotherapeutics 

Boinapally S, Alati S, Jiang Z, Yan Y, Lisok A, Singh R, Lofland G, Minn I, Hobbs RF, Pomper MG, Banerjee SR, 2023 Aug Molecules 28

Detection of Biochemically Recurrent Prostate Cancer with [18F]DCFPyL PET/CT: An Updated Systematic Review and Meta-Analysis with a Focus on Correlations with Serum Prostate-Specific Antigen Parameters 

Sadaghiani MS, Sheikhbahaei S, Al-Zaghal A, Solnes LB, Pomper MG, Oldan JD, Ulaner GA, Gorin MA, Rowe SP, 2023 Aug Tomography 9 1504-1514

Expression of the excitatory opsin ChRERα can be traced longitudinally in rat and nonhuman primate brains with PET imaging 

Bonaventura J, Boehm MA, Jedema HP, Solis O, Pignatelli M, Song X, Lu H, Richie CT, Zhang S, Gomez JL, Lam S, Morales M, Gharbawie OA, Pomper MG, Stein EA, Bradberry CW, Michaelides M, 2023 Jul Science Translational Medicine 15

Pilot imaging of the colony stimulating factor 1 receptor in the brains of virally-suppressed individuals with HIV 

Rubin LH, Du Y, Sweeney SE, O'Toole R, Harrington CK, Jenkins K, Lesniak WG, Veenhuis RT, Dastgheyb R, Severson J, Fan H, Holt DP, Hall AW, Dannals RF, Horti AG, Pomper MG, Coughlin JM, 2023 Jul AIDS 37 1419-1424

First-in-human imaging using [11C]MDTC: a radiotracer targeting the cannabinoid receptor type 2 

Du Y, Coughlin JM, Brosnan MK, Chen A, Shinehouse LK, Abdallah R, Lodge MA, Mathews WB, Liu C, Wu Y, Minn I, Finley P, Hall AW, Lesniak WG, Dannals RF, Horti AG, Pomper MG, 2023 Jul European Journal of Nuclear Medicine and Molecular Imaging 50 2386-2393

Exploring the potential of the novel imidazole-4,5-dicarboxyamide chemical exchange saturation transfer scaffold for pH and perfusion imaging 

Bo S, Stabinska J, Wu Y, Pavuluri KD, Singh A, Mohanta Z, Choudhry R, Kates M, Sedaghat F, Bhujwalla Z, Pomper MG, McMahon MT, 2023 Jun NMR in Biomedicine 36

Lack of repeatability of radiomic features derived from PET scans: Results from a 18F-DCFPyL test–retest cohort 

Werner RA, Habacha B, Lütje S, Bundschuh L, Kosmala A, Essler M, Derlin T, Higuchi T, Lapa C, Buck AK, Pienta KJ, Lodge MA, Eisenberger MA, Markowski MC, Pomper MG, Gorin MA, Frey EC, Rowe SP, Bundschuh RA, 2023 May Prostate 83 547-554

Multi-timepoint imaging with PSMA-targeted [18F]F-Florastamin PET/CT: lesion detection and comparison to conventional imaging 

Sheikhbahaei S, Bello Martinez R, Markowski MC, Eisenberger MA, Pienta KJ, Reyes D, Brosnan MK, Spiro E, AbdAllah R, Holt DP, Dannals RF, Werner RA, Pomper MG, Gorin MA, Solnes LB, Rowe SP, 2023 Apr Annals of Nuclear Medicine 37 246-254

6-O-(2-[18F]Fluoroethyl)-6-O-Desmethyl-Diprenorphine ([18F]FE-DPN) Preferentially Binds to Mu Opioid Receptors In Vivo 

Levinstein MR, Ventriglia EN, Gomez JL, Budinich RC, Marton J, Henriksen G, Holt DP, Dannals RF, Pomper MG, Zarate CA, Bonaventura J, Michaelides M, 2023 Apr Molecular Imaging and Biology 25 384-390

High Interobserver Agreement on PSMA PET/CT Even in the Absence of Clinical Data 

Bundschuh RA, Lütje S, Bundschuh L, Lapa C, Higuchi T, Hartrampf PE, Gorin MA, Kosmala A, Buck AK, Pomper MG, Rowe SP, Essler M, Sheikh GT, Werner RA, 2023 Mar Clinical Nuclear Medicine 48 207-212

Nucleolin mediates SARS-CoV-2 replication and viral-induced apoptosis of host cells 

Merino VF, Yan Y, Ordonez AA, Bullen CK, Lee A, Saeki H, Ray K, Huang T, Jain SK, Pomper MG, 2023 Mar Antiviral Research 211

Erratum: Targeted Theranostic 111In/Lu-Nanotexaphyrin for SPECT Imaging and Photodynamic Therapy 

Cheng MH, Overchuk M, Rajora MA, Lou JW, Chen Y, Pomper MG, Chen J, Zheng G, 2023 Jan Molecular Pharmaceutics 20 783

Small Molecules as Vectors for Radiopharmaceutical Therapy 

Rowe SP, Werner RA, Garg T, Gafita A, Voter AF, Sadaghiani MS, Markowski MC, Paller CJ, Zalutsky MR, Solnes LB, Pomper MG, 2023 Jan 349-367

Feasibility of Spectra-Based Quantification Algorithm for Non-Linear Photoacoustic Contrast Agents 

Serebrennikova L, Gao S, Murakami R, Boinapally S, Ray S, Pomper MG, Zhang HK, 2023

Re: “Overcoming Challenges Associated with 18F-DCFPyL PET Imaging in Prostate Cancer” 

Rowe SP, Voter AF, Werner RA, Zukotynski KA, Pomper MG, Gorin MA, Solnes LB, 2023 Canadian Journal of Urology 30 11465-11466

Elevated Body Mass Index Is Associated with Improved Overall Survival in Castration-Resistant Prostate Cancer Patients Undergoing Prostate-Specific Membrane Antigen–Directed Radioligand Therapy 

Hartrampf PE, Mihatsch PW, Seitz AK, Solnes LB, Rowe SP, Pomper MG, Kübler H, Bley TA, Bück AK, Werner RA, 2023 Journal of Nuclear Medicine 64 1272-1278

Non-Viral Gene Delivery to Hepatocellular Carcinoma via Intra-Arterial Injection 

Vaughan HJ, Zamboni CG, Luly KM, Li L, Gabrielson KL, Hassan LF, Radant NP, Bhardwaj P, Selaru FM, Pomper MG, Green JJ, 2023 International Journal of Nanomedicine 18 2525-2537

One Hundred Years of the Tracer Principle 

Hoberuck S, Zophel K, Pomper MG, Rowe SP, Gafita A, 2023 Journal of Nuclear Medicine 64 1998-2000

Fluence Compensation for Linear Array-Based Photoacoustic Imaging System Using Geometrical Depth Mapping 

Tang Y, Lesniak WG, Pomper MG, Zhang HK, 2023

Image acquisition and interpretation of 18F-DCFPyL (piflufolastat F 18) PET/CT: How we do it 

Rowe SP, Voter AF, Werner RA, Zukotynski KA, Pomper MG, Gorin MA, Solnes LB, 2023 Canadian Journal of Urology 30 11432-11437

PSMA-Targeted PET Radiotracer [18F]DCFPyL as an Imaging Biomarker in Inflammatory Bowel Disease 

Ismail MS, Peters DE, Rowe SP, Salavati A, Sharma S, Anders RA, Pomper M, Slusher BS, Selaru FM, 2023 Clinical and Experimental Gastroenterology 16 237-247